We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Combined with Genomic Surveillance Beats Humans at Detecting Infectious Disease Outbreaks in Hospital Settings

By LabMedica International staff writers
Posted on 23 Nov 2021

By coupling machine learning with whole genome sequencing, scientists have greatly improved the quick detection of infectious disease outbreaks within a hospital setting over traditional methods for tracking outbreaks. More...

The process developed by scientists at the University of Pittsburgh School of Medicine (Pittsburgh, PA, USA) and Carnegie Mellon University (Pittsburgh, PA, USA) indicates a way for health systems to identify and then stop hospital-based infectious disease outbreaks in their tracks, cutting costs and saving lives. The Enhanced Detection System for Healthcare-Associated Transmission (EDS-HAT) couples the recent development of affordable genomic sequencing with computer algorithms connected to the vast trove of data in electronic health records. When the sequencing detects that any two or more patients in a hospital have near-identical strains of an infection, machine learning quickly mines those patients’ electronic health records for commonalities – whether that be close proximity of hospital beds, a procedure using the same equipment or a shared health care provider – alerting infection preventionists to investigate and halt further transmission.

Ordinarily, this process requires clinicians to notice that two or more patients have a similar infection and alert their infection prevention team, which can then review patient records to attempt to find how the infection was transmitted. From November 2016 to November 2018, UPMC Presbyterian Hospital ran EDS-HAT with a six-month lag for a few select infectious pathogens often associated with health care-acquired infections nationwide, while continuing with real-time, traditional infection prevention methods. The team then investigated how well EDS-HAT performed. EDS-HAT detected 99 clusters of similar infections in that two-year period and identified at least one potential transmission route in 65.7% of those clusters. During the same period, infection prevention used whole genome sequencing to aid in the investigation of 15 suspected outbreaks, two of which revealed genetically related infections. If EDS-HAT had been running in real-time, the team estimates as many as 63 transmissions of an infectious disease from one patient to another could have been prevented. It also would have saved the hospital as much as USD 692,500.

In one case-study, EDS-HAT found an outbreak of vancomycin-resistant Enterococcus faecium that it traced to an interventional radiology procedure involving injection of sterile contrast that was being performed according to manufacturer instructions. Due to EDS-HAT detecting the outbreak, UPMC alerted the manufacturer to the instructions that led to faulty sterilization practices. UPMC plans to introduce EDS-HAT in real-time at UPMC Presbyterian Hospital and expects this innovation to benefit other infection prevention and control programs in the future. And the original EDS-HAT, which primarily focused on drug-resistant bacterial pathogens, will soon be expanding to incorporate sequencing of respiratory viruses, including COVID-19.

“The current method used by hospitals to find and stop infectious disease transmission among patients is antiquated. These practices haven’t changed significantly in over a century,” said senior author Lee Harrison, M.D., professor of infectious diseases at Pitt’s School of Medicine and epidemiology at Pitt’s Graduate School of Public Health. “Our process detects important outbreaks that would otherwise fly under the radar of traditional infection prevention monitoring.”

Related Links:
University of Pittsburgh School of Medicine 
Carnegie Mellon University 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automated Immunoassay Analyzer
SuperFlex™
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.